Comorbidities (excluding lymphoma) in Sjögren's syndrome

Rheumatology (Oxford). 2021 May 14;60(5):2075-2084. doi: 10.1093/rheumatology/key329.

Abstract

The information about comorbidities (excluding lymphoma) in primary Sjögren's syndrome (pSS) is relatively scarce. Cardiovascular disease, infections, musculoskeletal conditions or malignancy are likely the most relevant comorbid conditions in pSS. Different infections (particularly oral candidal infections) and fibromyalgia are extremely frequent in the daily clinical practice. On the other hand, the incidence of cardiovascular events and cancer in pSS is low, so information about them comes from large epidemiological studies or meta-analysis. For this reason, preclinical vascular disease is investigated by different techniques, demonstrating the presence of early atherosclerosis in pSS patients. Coronary events could be slightly more frequent in pSS than in the general population. The overall risk of malignancy in pSS patients seems to be slightly increased, likely due to excess occurrence of lymphoma. An association between pSS and thyroid cancer might exist, although it should be confirmed by further investigations.

Keywords: atherosclerosis; cancer; cardiovascular events; comorbidity; fibromyalgia; infection; malignancy; oral infection; primary Sjögren’s syndrome.

Publication types

  • Review

MeSH terms

  • Atherosclerosis / epidemiology*
  • Comorbidity
  • Humans
  • Infections / epidemiology*
  • Neoplasms / epidemiology*
  • Prevalence
  • Sjogren's Syndrome / epidemiology*